Breen, Danna
Pfizer (United States)
3 papers on CoChatORCID 0000-0002-6460-8555
Most cited papers
- Verified
GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans
Patel, S., Alvarez-Guaita, A., Melvin, A., Rimmington, D., Dattilo, A., Miedzybrodzka, E. L., Cimino, I., Maurin, A.-C., Roberts, G. P., Meek, C. L., et al. (2019) · Cell Metabolism
GDF15 and Related BiomarkersRegulation of Appetite and Obesity
Cited by 509
- Verified
Latest approaches for the treatment of obesity
Jackson, V. M., Breen, D. M., Fortin, J.-P., Liou, A., Kuzmiski, J. B., Loomis, A. K., Rives, M.-L., Shah, B., & Carpino, P. A. (2015) · Expert Opinion on Drug Discovery
Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity
Cited by 132
- Verified
Growth differentiation factor 15 ( GDF15 ) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms
Ghidewon, M., Wald, H. S., McKnight, A. D., De Jonghe, B. C., Breen, D. M., Alhadeff, A. L., Borner, T., & Grill, H. J. (2022) · Diabetes, Obesity and Metabolism
Regulation of Appetite and ObesityGDF15 and Related Biomarkers
Cited by 51
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free